epilepsy/albumin

Lyen an sove nan clipboard la

Chwazi kalite sòt

8 rezilta yo

Vitamine D in Drug Resistant Epilepsy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The goal of this study is to establish the effect of the compensation of vitamin D deficiency in the treatment of drug-resistant epilepsy with a high level of evidence in a large population. For that, the investigator aim to perform a controlled multicentre prospective double-blind randomized study

Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The goal of the present open label study is to obtain pilot data to evaluate the efficacy and safety of KD in adults with intractable epilepsy. Investigators will evaluate the effect of KD on seizure frequency and on adverse events. Investigators will also evaluate serum levels of the ketone body,

Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

I Purpose: The purpose of this multi-centre study is to further assess the safety and efficacy of the proposed lysine restricted diet in confirmed ATQ deficient PDE patients. II Hypothesis: Restricting dietary lysine intake in infants from age 3 months or less with confirmed diagnosis of

To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Patients with type 2 diabetes mellitus with and without diabetic nephropathy will be identified from clinical records and approached for their interest in participating in the study. Written informed consent will be obtained from patients who qualify according to the eligibility criteria and agree

HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

All participants will be treated with valproic acid (VPA) at a starting dose of 15 mg/kg/day orally in divided doses. This dose produces a VPA plasma level of 346-693 μM and is the recommended starting dose for patients with seizure disorder. Each week a pre-dose serum VPA level will be determined

Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Adult subjects with or without diabetes mellitus Eligibility Criteria: undergoing intravenous contrast administration for computerized axial tomography (CAT Scan) as inpatients. Subjects will be excluded if they have end-stage renal disease (on dialysis or peritoneal dialysis); any known history of

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This study is an eight-week, randomized, placebo-controlled, parallel group, fixed dose trial comparing two doses of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor positive modulator, Org 24448, added to a stable dose of atypical antipsychotic medication in 135 patients

Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Depakote (Abbott Laboratories, Abbott Park, IL) is an anti-convulsant medication used to treat epilepsy [1] and mania associated with bipolar disorder [2, 3]. Depakote also is used as a prophylaxis for migraine headache [4]. One side effect of Depakote that negatively influences its appeal to health

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye